LBFri-27 - LBFri-34 LB Neuroendocrinology and Pituitary- Friday

Program: Late-Breaking Abstracts
Friday, April 1, 2016: 1:15 PM-3:15 PM
Hall AB1 (BCEC)

Sakine Sever, MD, Endocrinology, Baylor College of Medicine, Houston, TX, Marco Marcelli, MD, Division of Diabetes, Endocrinology and Metabolism, Baylor College of Medicine VAMC, Houston, TX, Helen Lin, PhD, Michael E. DeBakey VA Medical Center, Houston, TX, Laura Acion, PhD, Psychiatry, University of Iowa, Iowa City, IA, Ricardo Jorge, MD, Neuropsychiatry, Baylor College of Medicine, Houston, TX and Jose Manuel Garcia, MD, PhD, Endocrinology, University of Washington, Seattle, WA
Poster Board Number: LBFri-29
Rong Li1, Honglu Diao2, Fei Zhao3, Shuo Xiao, Ph.D.4, Elizabeth A. Dudley1, Ahmed E. El Zowalaty1, Mark P Mattson5 and Xiaoqin Ye6, (1)Toxicology program, University of Georgia, Athens, GA
(2)Reproductive medical center, Hubei University of Medicine, Shiyan, China
(3)Reproductive developmental biology group, National Institute of Environmental Health Science, Research triangle park, NC
(4)Feinberg School of Medicine, Northwestern University, Chicago, IL
(5)Laboratory of Neuroscience, Biomedical Research Center, Baltimore, MD
(6)Physiology and pharmacology department, University of Georgia, Athens, GA
Poster Board Number: LBFri-27
Jung-Won Woo, PhD1, Eun Jig Lee, MD PhD2, Jung Hee Kim, MD3, Byung-Joon Kim, MD PhD4, Jochen Schopohl, MD5, Sandor Magony, MD6, Aldona Kowalska, MD PhD7, Svetozar Damjanovic, MD PhD8, Tae Kyung Kim, PhD1, Young-Joo Ahn9, Woo Ick Jang, MD PhD9 and Young-Chul Sung, PhD1, (1)Genexine, Inc., Korea, The Republic of
(2)Yonsei University College of Medicine, Korea, The Republic of
(3)Seoul National University College of Medicine, South Korea
(4)Gachon University of Medicine and Science, Korea, The Republic of
(5)University of Munich Medizinsche Klinik, Germany
(6)University of Szeged, HUNGARY
(7)Swietokrzyskie Centrum Onkologii, Poland
(8)Clinical Center of Serbia, Serbia
(9)Handok, Inc., Korea, The Republic of
Poster Board Number: LBFri-28
Sang Mee Lee, Alteogen Inc, Deajeon, SOUTH KOREA, Jung-soo Cho, Alteogen Inc, Daejeon, SOUTH KOREA, Hye-shin Chung, Biotechnology & Bioengineering, Han Nam university, Daejeon, SOUTH KOREA and Soon Jae Park, Alteogen Inc., Daejeon, SOUTH KOREA
Poster Board Number: LBFri-30
April Au1, Deborah Schwartz2, Andrea Eisen3, Amy Finch4, Elizabeth Hampson5, Taymaa May6, Wendy Meschino7, Joan Murphy8, Steven Narod4, Mary Tierney3 and Gillian Einstein1, (1)University of Toronto, Toronto, ON, CANADA
(2)University of Toronto, ON, Canada
(3)Sunnybrook Health Sciences Centre, ON, Canada
(4)Women's College Research Institute, ON, Canada
(5)Western University, London, ON, CANADA
(6)Princess Margaret Cancer Centre, ON, Canada
(7)North York General Hospital, ON, Canada
(8)Trillium Health Partners, ON, Canada
Poster Board Number: LBFri-31
Alexandra Labarthe1, Philippe Zizzari1, Christophe Chauveau2, Oriane Fiquet1, Johannes Veldhuis3, Emil Egecioglu4, Mohammad Bohlooly5, Jacques P Epelbaum1 and Virginie Tolle1, (1)Centre de Psychiatrie et Neurosciences, INSERM UMR-S 894, Université Paris Descartes, Paris, France
(2)EA 4490 PMOI, Université Lille2-ULCO, Boulogne-sur-Mer, France
(3)Endocrine Research Unit, Mayo Clinic School of Medicine, Rochester, MN
(4)Section for Gastroenterology, Diabetes and Endocrinolog, Institution of Experimental Medical Sciences, Lund University, Lund, Sweden
(5)RAD-Transgenic, Discovery Science, AstraZeneca R&D Mölndal, Mölndal, Sweden, Sweden
Poster Board Number: LBFri-32